Recently, It also has been reported that Ars2 is overexpressed in human hepato cellular carcinoma (HCC) and cholangiocarcinoma and therefore considered Ars2 as a prognostic, diagnostic marker, even a potential target for therapeutic intervention25,26. This evidence concerns the gene SRRT and cholangiocarcinoma.